Why Is Medtronic Spinning Off Its Diabetes Business?

Why Is Medtronic Spinning Off Its Diabetes Business?

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market. The post Why Is Medtronic Spinning Off Its Diabetes Business? appeared first on MedCity News.

Vivani files with SEC to spin off neurostim business

Vivani Medical (Nasdaq:VANI) announced today that it filed a Form 10 registration statement with the SEC to spin off its neurostimulation unit. The company said earlier this year that it plans to spin off Cortigent, a division that develops brain implants. The company wants to create two focused companies dedicated to driving current and future value in their respective therapeutic areas. Vivani aims to continue advancing its miniature GLP-1 the…